Home Science Health and Medicine SAPIEN 3 improves 30-day outcomes for major endpoints, study suggests
SAPIEN 3 improves 30-day outcomes for major endpoints, study suggests
The SAPIEN 3 heart valve demonstrated lower death, stroke and paravalvular leak rates than earlier generation devices in patients at high risk for surgery and showed encouraging results in intermediate-risk patients, according to new research.
